Preparation and characterization of glassy celecoxib

Drug Development and Industrial Pharmacy

Volumn 29, Issue 7, 2003, Pages 739-744

  Paradkar, A R ^a   Chauhan, B ^a   Yamamura, S ^b   Pawar, A P ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Celecoxib; Compressibility; Crystallization; Degree of crystallinity; Glassy state; X ray powder diffraction

Indexed keywords

CELECOXIB;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; GLASS TRANSITION TEMPERATURE; HECKEL PLOT ANALYSIS; HYDROGEN BOND; INFRARED SPECTROSCOPY; MATHEMATICAL ANALYSIS; MELTING POINT; MOLECULAR STABILITY; PULVERIZATION; STATISTICAL SIGNIFICANCE; TABLET COMPRESSION; TABLET FRIABILITY; THIN LAYER CHROMATOGRAPHY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, THIN LAYER; CRYSTALLIZATION; DRUG STABILITY; POWDER DIFFRACTION; PYRAZOLES; SOLUTIONS; SPECTROPHOTOMETRY, INFRARED; SULFONAMIDES; TEMPERATURE; TIME FACTORS; X-RAY DIFFRACTION;

EID: 0042347584     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120021773     Document Type: Article

References (18)

1. Broman, E.; Khoo, C.; Taylor, L.S. A comparison of alternative polymer excipients and processing methods for making solid dispersion of a poorly water soluble drug. Int. J. Pharm. 2001, 222, 139-151.
2. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersion. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
3. Lian, Y. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Ad. Drug Del. Rev. 2001, 48, 27-42.
4. Fukuoka, E.; Makita, M.; Yamamura, S. Glassy state of pharmaceuticals II: thermal properties and stability of glassy pharmaceuticals and their binary glass systems. Chem. Pharm. Bull. 1989, 37, 1047-1057.
5. Sric, S.; Kerc, J.; Urleb, U.; Zupancic, I.; Lahajnar, G.; Kofler, B.; Smid-Korbar, J. Investigation of felodipine polymorphism and its glassy state. Int. J. Pharm. 1992, 87, 1-10.
6. Yamaguchi, T.; Nishimura, M.; Okamata, R.; Takeuchi, T.; Yamamoto, K. Chem. Phar. Bull. 1993, 41, 1812-1816.
7. Hancock, B.C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceuticals. J. Pharm. Sci. 1997, 86, 1-12.
8. Craig, D.Q.M.; Royall, P.G.; Kett, V.L.; Hopton, M.L. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharm. 1999, 2, 179-207.
9. Yamaguchi, T.; Nishimura, M.; Okamata, R.; Takeuchi, T.; Yamamoto, K. Glass formation of 4″-O-(4-methoxy phenyl) acetylosin and physicochemical stability of amorphous solid. Int. J. Pharm. 1992, 85, 87-96.
10. Yonemochi, E.; Kitahara, S.; Maeda, S.; Yamamura, S.; Oguchi, T.; Yamamoto, K. Physicochemical properties of amorphous clarithromycin obtained by spray drying & grinding. Eur. J. Pharm. Sci. 1999, 7, 331-338.
11. Fukuoka, E.; Makita, M.; Yamamura, S. Some physicochemical properties of glassy indomethacin. Chem. Pharm. Bull. 1986, 34, 4314-4321.
12. Hassan, M.A.; Najib, N.M.; Suleiman, M.S. Investigation of glebenclamide glass. Int. J. Pharm. 1991, 67, 131-137.
13. Strickland, W.A.; Busse, L.W.; Higuchi, T. J. Am. Pharm. Assoc. 1956, 45, 482.
14. Hermans, P.H.; Weidinger, A. Quantitative X-ray investigations on the crystallinty of cellulose fibres. J. App. Phy. 1948, 19, 491-506.
15. Bontea, D.; Caruntu, G.; Aelenei, N.J. The characterization of some silylcellulose derivatives by X-RD macromol. Sci. Pure Appl. Chem. 2000, A37, 395-405.
16. Fox, D.; Labes, M.M.; Wiessberger, A. Physics and Chemistry of the Organic Solid State; Interscience: New York, 1963; 572 pp.
17. Paradkar, A.R.; Pawar, A.P.; Chordiya, J.K.; Patil, V.B.; Ketkar, A.R. Spherical crystallization of celecoxib. Drug. Dev. Ind. Pharm. 2002, 28, 1213-1220.
18. Lerk, C.F. Consolidation and compaction of lactose. Drug Dev. Ind. Pharm. 1993, 19, 2359.